Craft

Celltrion Healthcare

Revenue

₩2 T

FY, 2022

Celltrion Healthcare Summary

Company Summary

Overview
Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis. It aims to provide medicines for Non-Hodgkin's Lymphoma(NHL), Chronic Lymphocytic Leukemia(CLL), Rheumatoid Arthritis(RA), Granulomatosis with Polyangiitis(GPA), Microscopic Polyangiitis(MPA), etc.
Type
Public
Status
Active
Founded
2002
HQ
Incheon, KR | view all locations
Website
https://www.celltrionhealthcare.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Incheon, Incheon HQ

    Korea (Republic of)

    19 Academy-ro 51beon-gil, Yeonsu-gu

Celltrion Healthcare Financials

Summary Financials

Revenue (Q3, 2023)
₩647.6B
Gross profit (Q3, 2023)
₩171.1B
Net income (Q3, 2023)
₩44.8B
Cash (Q3, 2023)
₩358.3B
EBIT (Q3, 2023)
₩56.6B

Footer menu